Cover Image
Market Research Report

Global Personalized Medicine Market - Types, Technologies and Applications

Published by Industry Experts Product code 720540
Published Content info 386 Pages, 171 Charts
Delivery time: 1-2 business days
Price
Back to Top
Global Personalized Medicine Market - Types, Technologies and Applications
Published: October 9, 2018 Content info: 386 Pages, 171 Charts
Description

Report Synopsis

Personalized medicine has a huge potential in leading the healthcare industry with drastic changes with a key focus on diseases understanding & management integrated with advanced analytics, patient data, customized medicines and other possibilities. Personalized Medicine will transform the entire pharmaceutical value chain, from early development to companies' go-to-market models, and the next five years will be a crucial window for pharmaceutical companies to capitalize on this promise. Companies simply cannot sit on the sidelines during this period. Instead, they need to take risks and more actively engage with stakeholders throughout the healthcare ecosystem. However, there seems to be some challenges such as an unclear regulatory framework, insufficient access to high-quality data, data privacy issues and lack of standards.

Global Personalized Medicine market is expected to witness a robust CAGR of over 11% during the 2017-2024 analysis period and projected to touch US$194.4 billion by 2024 from an estimated US$92.4 billion in 2017. By application, Oncology is estimated the largest market accounting for about 30% throughout the analysis period.

Research Findings & Coverage

  • The global personalized medicine market is explored in this study with respect to product types, technologies and major applications
  • The exclusive analysis has been carried out for each product type, technology and major application of personalized in all major regions for the analysis period
  • Precision Medicine Enhanced through Artificial Intelligence and Blockchain
  • Personalized Cancer Therapy Gets a Boost from Patient-Derived Tumor Organoids
  • Future of Personalized Medicine Linked to Microbiomics
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled - 73
  • The industry guide includes the contact details for 115 companies

Product Outline

The report analyzes the market for key types of Personalized Medicine including:

  • Personalized Medicine Diagnostics
  • Personalized Medical Care
  • Personalized Medicine Therapeutics
  • Personalized Nutrition & Wellness

The study reviews global market for Personalized Medicine technologies comprising:

  • Pharmacogenomics
  • Point-of-Care Testing
  • Stem Cell Therapy
  • Pharmacoproteomics
  • Pharmacogenetics
  • Other Technologies

The following application areas of Personalized Medicine are analyzed in this report:

  • Oncology
  • Central Nervous System (CNS)
  • Immunology
  • Respiratory
  • Other Applications

Analysis Period, Units and Growth Rates

  • The report reviews, analyzes and projects the global Personalized Medicine market for the period 2015-2024 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2017 through 2024

Geographic Coverage

  • North America (The United States, Canada and Mexico)
  • Europe (France, Germany, Italy, the United Kingdom and Rest of Europe)
  • Asia-Pacific (China, India, Japan and Rest of Asia-Pacific)
  • South America (Argentina, Brazil and Rest of South America)
  • Rest of World
Table of Contents
Product Code: BT013

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

  • 1.1. Product Outline
    • 1.1.1. The Human Genome: What is It?
    • 1.1.2. Personalized Medicine Defined
    • 1.1.3. Personalized Medicine's Influence on Large Scale Studies
    • 1.1.4. Gazing into the Crystal Ball: What the Future Holds for Personalized Medicine
    • 1.1.5. Ramifications of Personalized Medicine for Healthcare Systems
      • 1.1.5.1. Pharmaceutical Industry
      • 1.1.5.2. Diagnostics Industry
      • 1.1.5.3. Insurers
      • 1.1.5.4. Physicians
      • 1.1.5.5. Government Agencies
      • 1.1.5.6. Patients
    • 1.1.6. Personalized Medicine Product Types
      • 1.1.6.1. Personalized Medicine Diagnostics
        • 1.1.6.1.1. Genetic Testing
        • 1.1.6.1.2. Direct-to-consumer Diagnostics
      • 1.1.6.2. Personalized Medicine Therapeutics
        • 1.1.6.2.1. Personalized Medicine Will Transform the Pharmaceutical and Healthcare Industries
        • 1.1.6.2.2. Personalized Medical Devices
        • 1.1.6.2.3. Genomic Medicine
      • 1.1.6.3. Personalized Medical Care
        • 1.1.6.3.1. Telemedicine
        • 1.1.6.3.2. Health Information Technology
        • 1.1.6.3.3. Diseases Management
      • 1.1.6.4. Personalized Nutrition & Wellness
        • 1.1.6.4.1. Complementary and Alternative Medicine
    • 1.1.7. Personalized Medicine Technologies
      • 1.1.7.1. Pharmacogenomics
        • 1.1.7.1.1. Drug Metabolism
        • 1.1.7.1.2. Applications
      • 1.1.7.2. Point-of-Care Testing
        • 1.1.7.2.1. Tests that are Most Apt for Specific Scenarios
        • 1.1.7.2.2. Advantages
      • 1.1.7.3. Stem Cell Therapy
        • 1.1.7.3.1. Treatment with Stem Cells
        • 1.1.7.3.2. Current Therapies
        • 1.1.7.3.3. Future Treatments
      • 1.1.7.4. Pharmacoproteomics
      • 1.1.7.5. Pharmacogenetics
        • 1.1.7.5.1. Prediction of Drug-Drug Interactions
        • 1.1.7.5.2. Integration of Pharmacogenetics with the Healthcare System
        • 1.1.7.5.3. Pharmacogenetic Tests
      • 1.1.7.6. Other Personalized Medicine Technologies
        • 1.1.7.6.1. Biochips
          • 1.1.7.6.1.1. Fabrication of Microarrays
          • 1.1.7.6.1.2. Protein Biochip Array and Other Microarray Technologies
          • 1.1.7.6.1.3. Biochips Applications: Ranging from Diagnostics to Personalized Medicine
        • 1.1.7.6.2. Metabolomics
          • 1.1.7.6.2.1. Analytical Technologies
            • 1.1.7.6.2.1.1. Separation Methods
              • Gas Chromatography (GC)
              • High Performance Liquid Chromatography (HPLC)
              • Capillary Electrophoresis (CE)
            • 1.1.7.6.2.1.2. Detection Methods
              • Mass Spectrometry (MS)
              • Nuclear Magnetic Resonance (NMR) Spectroscopy
            • 1.1.7.6.2.2. Major Application Areas
        • 1.1.7.6.3. Molecular Diagnostics
          • 1.1.7.6.3.1. Molecular Diagnostics for Personalized Medicine
        • 1.1.7.6.4. Pharmacodynamics
        • 1.1.7.6.5. Pharmacokinetics
        • 1.1.7.6.6. SNP Genotyping
          • 1.1.7.6.6.1. Core Labs
          • 1.1.7.6.6.2. Hybridization-Based Methods
          • 1.1.7.6.6.3. Enzyme-Based Methods
          • 1.1.7.6.6.4. Other Post-Amplification Methods Based on Physical Properties of DNA
    • 1.1.8. Personalized Medicine Applications
      • 1.1.8.1. Oncology
        • 1.1.8.1.1. Personalized Medicine in Cancer Treatment
          • 1.1.8.1.1.1. The Promise of Personalized Medicine
          • 1.1.8.1.1.2. Personalized Medicine as a Treatment Approach
          • 1.1.8.1.1.3. Personalized Medicine Does Not Yet Apply to Everyone
          • 1.1.8.1.1.4. Personalized Medicine Research Moving Forward
        • 1.1.8.1.2. Examples of personalized medicine
      • 1.1.8.2. Central Nervous System (CNS)
        • 1.1.8.2.1. Personalized Medicine in Brain Metastases: A Plea for More Translational Studies
      • 1.1.8.3. Immunology
        • 1.1.8.3.1. Clinical Immunology
      • 1.1.8.4. Respiratory
        • 1.1.8.4.1. Respiratory System: Facts, Function and Diseases
        • 1.1.8.4.2. Diseases of the respiratory system
      • 1.1.8.5. Other Applications Of Personalized Medicine
        • 1.1.8.5.1. Psychiatry
        • 1.1.8.5.2. Antiviral Therapy
        • 1.1.8.5.3. Diabetes
        • 1.1.8.5.4. Coagulation and blood transfusion safety

2. KEY MARKET TREDNS

  • 2.1. Precision Medicine Enhanced through Artificial Intelligence and Blockchain
    • Artificial Intelligence for Genome Sequencing
  • 2.2. Personalized Cancer Therapy Gets a Boost from Patient-Derived Tumor Organoids
  • 2.3. Patient-Derived Organoid Models of Bladder Cancer Help in Determining Tumor Evolution and Drug Response
  • 2.4. Personalized Immunotherapy in Cancer Improved through Tumor Organoids
  • 2.5. Future of Personalized Medicine Linked to Micorbiomics
  • 2.6. Regenerated T Cells Can Possibly Used in Personalized Medicine

3. KEY GLOBAL PLAYERS

  • Abbott Laboratories, Inc. (United States)
  • Abbott Molecular, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • Dako A/S (Denmark)
  • Amgen, Inc. (United States)
  • Decode Genetics (Iceland)
  • Astrazeneca Plc (United Kingdom)
  • Astellas Pharma, Inc. (Japan)
  • Bayer AG (Germany)
  • Bayer Healthcare Pharmaceuticals, Llc (Germany)
  • Celgene Corporation (United States)
  • Glaxosmithkline Plc (United Kingdom)
  • Illumina, Inc. (United States)
  • Johnson & Johnson (United States)
  • Laboratory Corporation of America (United States)
  • Merck KGaA (Germany)
  • Sigma-Aldrich Corporation (United States)
  • Novartis AG (Switzerland)
  • Roche Holding AG (Switzerland)
  • Roche Diagnostics Corporation (United States)
  • Siemens AG (Germany)
  • Siemens Healthcare GmbH (Germany)
  • Siemens Healthcare Diagnostics, Inc. (United States)
  • Takeda Pharmaceutical Company Limited (Japan)

4. KEY BUSINESS AND PRODUCT TRENDS

  • Bayer AG and Haplogen GmbH Enter into Agreement
  • Almac Discovery Ltd, Elasmogen Ltd and Innovate UK Form an Alliance on VNAR Based Oncology Platform
  • Haplogen GmbH and Bayer AG Join Hands for Drug Discovery and Development
  • Amgen, Inc and Cedars-Sinai Medical Center Collaborate on Research Programs in Personalized Medicine
  • LEO Pharma A/S to Acquire Bayer's Dermatology Unit
  • Biocartis Group NV Introduces Innovative Idylla™ MSI Assay
  • GlaxoSmithKline Plc and 23andMe Collaborate on Drug Development Using Human Genetics
  • MD Anderson Cancer Center and Bayer AG Collaborate on Cancer Treatment Medicine
  • FDA Approval for Beckman Coulter's Troponin (hsTnI) Assays
  • Roche and Foundation Medicine, Inc Enter into Agreement
  • LabCorp and Unilabs Join Hands on Personalized Medicine Offering
  • Abbott Develops Deep Brain Stimulation System, Life-Changing Treatment
  • Biocartis Group NV Demonstrate Idylla™ EGFR Mutation Test
  • Myriad Genetics Inc to Acquire Counsyl, Inc
  • Owlstone Medical Ltd Enters into Collaboration with AstraZeneca Plc
  • Boehringer Ingelheim GMBH and OSE Immunotherapeutics SA Enter into Partnership
  • PerkinElmer, Inc and Helix Enter into Agreement on Exome-based Personal Genomics
  • Daiichi Sankyo Co., Ltd and DarwinHealth Collaboration on Novel Cancer Drug Development
  • Roche, Foundation Medicine Inc, and DIAN Diagnostics Collaborate to Progress Personalized Cancer Care in China
  • Loxo Oncology and Illumina, Inc Collaborate on Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics
  • Vineti and Deloitte Work on Personalized Medicine Development
  • Thermo Fisher Scientific, Inc Acquires IntegenX, Inc
  • Siemens Healthineers Launches 1.5T MRI Scanner Magnetom Sola
  • Abbott Laboratories Inc and SurModics, Inc Enter into Agreement on Next-Generation Drug-Coated Balloon
  • Almac Diagnostics and DNAnexus Join Forces
  • Roche Acquires Flatiron Health, Inc.
  • Myriad Genetics, Inc Enters an Agreement with AstraZeneca Plc
  • BIOCRATES Life Sciences AG Acquires Metanomics Health GmbH
  • Roche and GE Healthcare Enter into Partnership on Individualized Oncology and Critical Care Treatment
  • Illumina, Inc and KingMed Diagnostics Agree on Next-Generation Sequencing (NGS) Technology
  • Bayer AG Receives Chinese Food and Drug Administration (CFDA) Approval for Stivarga® (Regorafenib) Tablets for the Second-line Treatment of Patients with Hepatocellular Carcinoma (HCC)
  • Fortuna Fix Inc Raises Funds for Stem Cell Treatments for Parkinson's Disease and Spinal Cord Injuries
  • Bayer AG and Loxo Oncology Inc to Develop and Commercialize Two Novel Oncology Therapies
  • Biocartis Group NV Unveils Two New CE-marked IVD Liquid Biopsy Tests
  • Boehringer Ingelheim GmbH and Dicerna Pharmaceuticals, Inc Agree on Nonalcoholic Steatohepatitis (NASH) Treatment Development
  • Laboratory Corporation of America® Holdings Launch PD-L1 IHC 28-8 PharmDx Assay
  • Laboratory Corporation of America Holdings Company Enters into Partnership with MedReleaf Corp
  • Siemens Healthineers Develops Nexaris Therapy Suite
  • Abbott Laboratories, Inc Receives FDA 510(k) Clearance for Alinity™ CI-Series Instruments
  • The National Institutes of Health (NIH) and Bio-Pharmaceutical Companies Collaborate on Personalized Medicine Approach to Cancer Care
  • Myriad Genetics, Inc Offers Personalized Medicine Tests for Breast Cancer
  • Abbott Laboratories Inc, Acquires Alere, Inc
  • Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) Develops Cancer Immunotherapies and Advance Personalized Medicine
  • Bristol-Myers Squibb and Daiichi Sankyo Co., Ltd Enter into Clinical Collaboration in HER2-Expressing Breast and Bladder Cancers
  • AstraZeneca plc and Takeda Pharmaceutical Company Limited today announce Partnership
  • Amgen's Therapy Vectibix® (panitumumab) Receives FDA Approval
  • Blue Shield of California Develops Agendia's MammaPrint® Technology
  • Baxter International, Inc and Dorizoe Lifesciences Limited Enter into Agreement
  • Thermo Fisher Scientific Inc and BIOCRATES Life Sciences AG Develop AbsoluteIDQ® p400 HR kit
  • Agilent Technologies Inc, Expands the Usage of Dako PD-L1 IHC 28-8 PharmDx Test in Europe
  • Abbott Laboratories Inc Unveils Nutrition Drinks
  • Myriad Genetics Inc and BeiGene, Ltd Collaborate on Companion Diagnostics Development for Personalized Medicine Drive
  • Illumina, Inc Reveals Somatic Genetic Alterations to Clinical Interpretation of Variants in Cancer (CIViC)
  • Almac Diagnostics and EORTC Join Forces on Tumor Molecular Profiling
  • Bristol-Myers Squibb and GRAIL, Inc Enter into Personalized Medicine Collaboration
  • GRAIL, Inc Invests Heavily in New Early Detection Techniques for Cancer
  • Novartis Pharmaceuticals Corporation and Cota Inc Agree to Develop Breast Cancer Treatment
  • Baxter International, Inc and ScinoPharm Taiwan, Ltd Enter into Strategic Partnership
  • Agilent Technologies Inc to Acquire Multiplicom N.V
  • Abbott Introduces New Ensite™ Precision Cardiac Mapping System
  • Royal Philips and Illumina Inc Collaborate on Combined Genomics Solutions for Oncology
  • Bayer AG and Leica Biosystems Develop Companion Diagnostic Test for Cancer Patients
  • Genomic Health, Inc reveals Results from Multiple Oncotype DX® Studies
  • Baxter International, Inc Acquires Claris Injectables Limited
  • NantHealth Inc and Oncotest-Teva Enter into Agreement
  • Asuragen Inc., Introduces QuantideX® NGS RNA Lung Cancer Kit
  • Thermo Fisher Scientific, Inc Enters into Distribution Agreement with Biocartis Group NV
  • Johns Hopkins University and Bristol-Myers Squibb Collaborate on Immune Checkpoint-Based Cancer Therapy
  • Danaher Corporation Acquires Cepheid, Inc
  • Assurex Health, Inc. Presents GeneSight® Personalized Medicine Test for Anxiety Disorder
  • IBM Watson Health and Quest Diagnostics Inc Introduce Watson-Powered Genomic Sequencing Service
  • Genomic Health, Inc Presents Personalized Medicine Studies at ESMO 2016 Congress
  • Genentech, Inc and BioNtech Agree on Personalized Cancer Vaccine Development
  • Asuragen Inc, Unveils AmplideX® PCR/CE C9orf72 Kit
  • DNA Genotek's ORAcollectDx Collection Device Receives FDA 510(k) Clearance
  • deCODE Genetics Discovers Rare Variation In The Sequence Of The Human Genome
  • QIAGEN NV Unveils Targeted RNA Panels for Next-Generation Sequencing
  • National Reference Laboratory and LabCorp Develop World-Class Assays for Personalized Medicine

5. GLOBAL MARKET OVERVIEW

  • 5.1. Global Personalized Medicine Market Overview by Product Type
    • 5.1.1. Personalized Medicine Product Type Market Overview by Global Region
      • 5.1.1.1. Personalized Medicine Diagnostics
      • 5.1.1.2. Personalized Medical Care
      • 5.1.1.3. Personalized Medicine Therapeutics
      • 5.1.1.4. Personalized Nutrition & Wellness
  • 5.2. Global Personalized Medicine Market Overview by Technology
    • 5.2.1. Personalized Medicine Technology Market Overview by Global Region
      • 5.2.1.1. Pharmacogenomics
      • 5.2.1.2. Point-of-Care Testing
      • 5.2.1.3. Stem Cell Therapy
      • 5.2.1.4. Pharmacoproteomics
      • 5.2.1.5. Pharmacogenetics
      • 5.2.1.6. Other Technologies
  • 5.3. Global Personalized Medicine Market Overview by Application
    • 5.3.1. Personalized Medicine Application Market Overview by Global Region
      • 5.3.1.1. Oncology
      • 5.3.1.2. Central Nervous System (CNS)
      • 5.3.1.3. Immunology
      • 5.3.1.4. Respiratory
      • 5.3.1.5. Other Applications

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA

  • 6.1. North American Personalized Medicine Market Overview by Geographic Region
  • 6.2. North American Personalized Medicine Market Overview by Product Type
  • 6.3. North American Personalized Medicine Market Overview by Technology
  • 6.4. North American Personalized Medicine Market Overview by Application
  • 6.5. Major Market Players
    • Abbott Laboratories, Inc. (United States)
    • Agilent Technologies, Inc. (United States)
    • Amgen, Inc. (United States)
    • Asuragen, Inc. (United States)
    • Baxter International, Inc. (United States)
    • Beckman Coulter, Inc. (United States)
    • BG Medicine, Inc. (United States)
    • Biogen, Inc. (United States)
    • Bristol-Myers Squibb (United States)
    • Celera Corporation (United States)
    • Celgene Corporation (United States)
    • Celldex Therapeutics, Inc. (United States)
    • Cepheid, Inc. (United States)
    • DNA Genotek, Inc. (Canada)
    • Eli Lilly and Company (United States)
    • Exact Sciences Corporation (United States)
    • Exagen Diagnostics, Inc. (United States)
    • Genelex Corporation (The Unites States)
    • Genentech, Inc. (United States)
    • Genewiz, Inc. (United States)
    • Genomic Health, Inc. (United States)
    • Genzyme Corporation (United States)
    • Historx, Inc. (United States)
    • Hologic, Inc. (United States)
    • Illumina, Inc. (United States)
    • Ingenuity Systems, Inc. (United States)
    • Johnson & Johnson (United States)
    • Laboratory Corporation of America (United States)
    • Luminex Corporation (United States)
    • Millennium Health, LLC. (United States)
    • Mylan, N.V (United States)
    • Myriad Genetics, Inc. (United States)
    • Nanostring Technologies, Inc. (United States)
    • Perkinelmer, Inc. (United States)
    • Caliper Life Sciences, Inc. (United States)
    • Pfizer, Inc. (United States)
    • Precision Biologics, Inc. (United States)
    • Promega Corporation (United States)
    • Roche Diagnostics Corporation (United States)
    • Siemens Healthcare Diagnostics, Inc. (United States)
    • Sigma-Aldrich Corporation (United States)
    • ThermoFisher Scientific, Inc. (United States)
    • Life Technologies Corporation (United States)
  • 6.6. Country-wise Analysis of North American Personalized Medicine Market
    • 6.6.1. The United States
      • 6.6.1.1. United States Personalized Medicine Market Overview by Product Type
      • 6.6.1.2. United States Personalized Medicine Market Overview by Technology
      • 6.6.1.3. United States Personalized Medicine Market Overview by Application
    • 6.6.2. Canada
      • 6.6.2.1. Canadian Personalized Medicine Market Overview by Product Type
      • 6.6.2.2. Canadian Personalized Medicine Market Overview by Technology
      • 6.6.2.3. Canadian Personalized Medicine Market Overview by Application
    • 6.6.3. Mexico
      • 6.6.3.1. Mexican Personalized Medicine Market Overview by Product Type
      • 6.6.3.2. Mexican Personalized Medicine Market Overview by Technology
      • 6.6.3.3. Mexican Personalized Medicine Market Overview by Application

7. EUROPE

  • 7.1. European Personalized Medicine Market Overview by Geographic Region
  • 7.2. European Personalized Medicine Market Overview by Product Type
  • 7.3. European Personalized Medicine Market Overview by Technology
  • 7.4. European Personalized Medicine Market Overview by Application
  • 7.5. Major Market Players
    • Agendia B.V. (The Netherlands)
    • Astrazeneca Plc (United Kingdom)
    • Bayer AG (Germany)
    • Bayer Healthcare Pharmaceuticals (Germany)
    • Biocartis NV (Belgium)
    • Boehringer Ingelheim GmbH (Germany)
    • Cytolon AG (Germany)
    • Dako A/S (Denmark)
    • Decode Genetics (Iceland)
    • Eagle Genomics Ltd. (United Kindom)
    • Evotec AG (Germany)
    • GE Healthcare Ltd. (United Kingdom)
    • GlaxoSmithKline Plc (United Kingdom)
    • Intomics A/S (Denmark)
    • Medtronic Plc (Ireland)
    • Merck KGAa (Germany)
    • Novartis AG (Switzerland)
    • Novo Nordisk A/S (Denmark)
    • Qiagen N.V. (The Netherlands)
    • Roche Holding AG (Switzerland)
    • Sanofi (France)
    • Siemens AG (Germany)
    • Siemens Healthcare GmbH (Germany)
    • The European Personalised Medicine Association (EPEMED) (Luxembourg)
  • 7.6. Country-wise Analysis of European Personalized Medicine Market
    • 7.6.1. Germany
      • 7.6.1.1. German Personalized Medicine Market Overview by Product Type
      • 7.6.1.2. German Personalized Medicine Market Overview by Technology
      • 7.6.1.3. German Personalized Medicine Market Overview by Application
    • 7.6.2. The United Kingdom
      • 7.6.2.1. United Kingdom Personalized Medicine Market Overview by Product Type
      • 7.6.2.2. United Kingdom Personalized Medicine Market Overview by Technology
      • 7.6.2.3. United Kingdom Personalized Medicine Market Overview by Application
    • 7.6.3. France
      • 7.6.3.1. French Personalized Medicine Market Overview by Product Type
      • 7.6.3.2. French Personalized Medicine Market Overview by Technology
      • 7.6.3.3. French Personalized Medicine Market Overview by Application
    • 7.6.4. Italy
      • 7.6.4.1. Italian Personalized Medicine Market Overview by Product Type
      • 7.6.4.2. Italian Personalized Medicine Market Overview by Technology
      • 7.6.4.3. Italian Personalized Medicine Market Overview by Application
    • 7.6.5. Rest of Europe
      • 7.6.5.1. Rest of European Personalized Medicine Market Overview by Product Type
      • 7.6.5.2. Rest of European Personalized Medicine Market Overview by Technology
      • 7.6.5.3. Rest of European Personalized Medicine Market Overview by Application

8. ASIA-PACIFIC

  • 8.1. Asia-Pacific Personalized Medicine Market Overview by Geographic Region
  • 8.2. Asia-Pacific Personalized Medicine Market Overview by Product Type
  • 8.3. Asia-Pacific Personalized Medicine Market Overview by Technology
  • 8.4. Asia-Pacific Personalized Medicine Market Overview by Application
  • 8.5. Major Market Players
    • Astellas Pharma, Inc. (Japan)
    • Daiichi Sankyo Company Limited (Japan)
    • Mitsubishi Tanabe Pharma Corporation (Japan)
    • Takeda Pharmaceutical Company Limited (Japan)
  • 8.6. Country-wise Analysis of Asia-Pacific Personalized Medicine Market
    • 8.6.1. Japan
      • 8.6.1.1. Japanese Personalized Medicine Market Overview by Product Type
      • 8.6.1.2. Japanese Personalized Medicine Market Overview by Technology
      • 8.6.1.3. Japanese Personalized Medicine Market Overview by Application
    • 8.6.2. China
      • 8.6.2.1. Chinese Personalized Medicine Market Overview by Product Type
      • 8.6.2.2. Chinese Personalized Medicine Market Overview by Technology
      • 8.6.2.3. Chinese Personalized Medicine Market Overview by Application
    • 8.6.3. India
      • 8.6.3.1. Indian Personalized Medicine Market Overview by Product Type
      • 8.6.3.2. Indian Personalized Medicine Market Overview by Technology
      • 8.6.3.3. Indian Personalized Medicine Market Overview by Application
    • 8.6.4. Rest of Asia-Pacific
      • 8.6.4.1. Rest of Asia-Pacific Personalized Medicine Market Overview by Product Type
      • 8.6.4.2. Rest of Asia-Pacific Personalized Medicine Market Overview by Technology
      • 8.6.4.3. Rest of Asia-Pacific Personalized Medicine Market Overview by Application

9. SOUTH AMERICA

  • 9.1. South American Personalized Medicine Market Overview by Geographic Region
  • 9.2. South American Personalized Medicine Market Overview by Product Type
  • 9.3. South American Personalized Medicine Market Overview by Technology
  • 9.4. South American Personalized Medicine Market Overview by Application
  • 9.5. Country-wise Analysis of South American Personalized Medicine Market
    • 9.5.1. Brazil
      • 9.5.1.1. Brazilian Personalized Medicine Market Overview by Product Type
      • 9.5.1.2. Brazilian Personalized Medicine Market Overview by Technology
      • 9.5.1.3. Brazilian Personalized Medicine Market Overview by Application
    • 9.5.2. Argentina
      • 9.5.2.1. Argentinean Personalized Medicine Market Overview by Product Type
      • 9.5.2.2. Argentinean Personalized Medicine Market Overview by Technology
      • 9.5.2.3. Argentinean Personalized Medicine Market Overview by Application
    • 9.5.3. Rest of South America
      • 9.5.3.1. Rest of South American Personalized Medicine Market Overview by Product Type
      • 9.5.3.2. Rest of South American Personalized Medicine Market Overview by Technology
      • 9.5.3.3. Rest of South American Personalized Medicine Market Overview by Application

10. REST OF WORLD

  • 10.1. Rest of World Personalized Medicine Market Overview by Product Type
  • 10.2. Rest of World Personalized Medicine Market Overview by Technology
  • 10.3. Rest of World Personalized Medicine Market Overview by Application
  • 10.4. Major Market Players
    • Rosetta Genomics Ltd. (Israel)
    • TEVA Pharmaceutical Industries Ltd. (Israel)

PART C: GUIDE TO THE INDUSTRY

  • 1. NORTH AMERICA
  • 2. EUROPE
  • 3. ASIA-PACIFIC
  • 4. REST OF WORLD

PART D: ANNEXURE

  • 1. RESEARCH METHODOLOGY
  • 2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

  • Chart 1: Global Personalized Medicine Market (2017 & 2024) by Geographic Region in USD Million
  • Chart 2: Global Personalized Medicine Market by Product Type (2017 & 2024) in USD Million
  • Chart 3: Global Personalized Medicine Market by Technology (2017 & 2024) in USD Million
  • Chart 4: Global Personalized Medicine Market by Application - (2017 & 2024) in USD Million
  • Chart 5: Global Personalized Medicine Market Analysis (2015-2024) in USD Million
  • Chart 6: Global Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 7: Glance at 2015, 2017 and 2024 Global Personalized Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 8: Global Personalized Medicine Diagnostics Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 9: Glance at 2015, 2017 and 2024 Global Personalized Medicine Diagnostics Market Share (%) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 10: Global Personalized Medical Care Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 11: Glance at 2015, 2017 and 2024 Global Personalized Medical Care Market Share (%) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 12: Global Personalized Medicine Therapeutics Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 13: Glance at 2015, 2017 and 2024 Global Personalized Medicine Therapeutics Market Share (%) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 14: Global Personalized Nutrition & Wellness Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 15: Glance at 2015, 2017 and 2024 Global Personalized Nutrition & Wellness Market Share (%) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 16: Global Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 17: Glance at 2015, 2017 and 2024 Global Personalized Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 18: Global Market Analysis of Pharmacogenomics in Personalized Medicine (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 19: Glance at 2015, 2017 and 2024 Global Market Share (%)of Pharmacogenomics in Personalized Medicine by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 20: Global Market Analysis of Point-of-Care Testing in Personalized Medicine (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 21: Glance at 2015, 2017 and 2024 Global Market Share (%) of Point-of-Care Testing in Personalized Medicine by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 22: Global Market Analysis of Stem Cell Therapy in Personalized Medicine (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 23: Glance at 2015, 2017 and 2024 Global Market Share (%)of Stem Cell Therapy in Personalized Medicine by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 24: Global Market Analysis of Pharmacoproteomics in Personalized Medicine (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 25: Glance at 2015, 2017 and 2024 Global Market Share (%)of Pharmacoproteomics in Personalized Medicine by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 26: Global Market Analysis of Pharmacogenetics in Personalized Medicine (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 27: Glance at 2015, 2017 and 2024 Global Market Share (%)of Pharmacogenetics in Personalized Medicine by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 28: Global Market Analysis of Other Personalized Medicine Technologies (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 29: Glance at 2015, 2017 and 2024 Global Market Share (%)of Other Personalized Medicine Technologies by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 30: Global Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 31: Glance at 2015, 2017 and 2024 Global Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications
  • Chart 32: Global Market Analysis of Personalized Medicine in Oncology Application (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 33: Glance at 2015, 2017 and 2024 Global Market Share (%) of Personalized Medicine in Oncology Application by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 34: Global Market Analysis of Personalized Medicine in Central Nervous System Application Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 35: Glance at 2015, 2017 and 2024 Global Market Share (%) of Personalized Medicine in Central Nervous System Application by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 36: Global Market Analysis of Personalized Medicine in Immunology Application (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 37: Glance at 2015, 2017 and 2024 Global Market Share (%) of Personalized Medicine in Immunology Application by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 38: Global Market Analysis of Personalized Medicine in Respiratory Application (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 39: Glance at 2015, 2017 and 2024 Global Market Share (%) of Personalized Medicine in Respiratory Application by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World
  • Chart 40: Global Market Analysis of Personalized Medicine in Other Applications (2015-2024) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World in USD Million
  • Chart 41: Glance at 2015, 2017 and 2024 Global Market Share (%) of Personalized Medicine in Other Applications by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

  • Chart 42: Global Personalized Medicine Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 43: Glance at 2015, 2017 and 2024 Global Personalized Medicine Market Share (%) by Geographic Region - North America, Europe, Asia Pacific, South America and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA

  • Chart 44: North American Personalized Medicine Market Analysis (2015-2024) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 45: Glance at 2015, 2017 and 2024 North American Personalized Medicine Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 46: North American Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 47: Glance at 2015, 2017 and 2024 North American Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 48: North American Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 49: Glance at 2015, 2017 and 2024 North American Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 50: North American Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 51: Glance at 2015, 2017 and 2024 North American Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

The United States

  • Chart 52: United States Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 53: Glance at 2015, 2017 and 2024 United States Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 54: United States Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 55: Glance at 2015, 2017 and 2024 United States Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 56: United States Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 57: Glance at 2015, 2017 and 2024 United States Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

Canada

  • Chart 58: Canadian Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 59: Glance at 2015, 2017 and 2024 Canadian Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 60: Canadian Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 61: Glance at 2015, 2017 and 2024 Canadian Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 62: Canadian Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 63: Glance at 2015, 2017 and 2024 Canadian Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

Mexico

  • Chart 64: Mexican Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 65: Glance at 2015, 2017 and 2024 Mexican Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 66: Mexican Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 67: Glance at 2015, 2017 and 2024 Mexican Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 68: Mexican Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 69: Glance at 2015, 2017 and 2024 Mexican Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

EUROPE

  • Chart 70: European Personalized Medicine Market Analysis (2015-2024) by Geographic Region - Germany, United Kingdom, France, Italy and Rest of Europe in USD Million
  • Chart 71: Glance at 2015, 2017 and 2024 European Personalized Medicine Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy and Rest of Europe
  • Chart 72: European Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 73: Glance at 2015, 2017 and 2024 European Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 74: European Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 75: Glance at 2015, 2017 and 2024 European Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 76: European Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 77: Glance at 2015, 2017 and 2024 European Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

Germany

  • Chart 78: German Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 79: Glance at 2015, 2017 and 2024 German Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 80: German Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 81: Glance at 2015, 2017 and 2024 German Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 82: German Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 83: Glance at 2015, 2017 and 2024 German Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

The United Kingdom

  • Chart 84: United Kingdom Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 85: Glance at 2015, 2017 and 2024 United Kingdom Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 86: United Kingdom Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 87: Glance at 2015, 2017 and 2024 United Kingdom Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 88: United Kingdom Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 89: Glance at 2015, 2017 and 2024 United Kingdom Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

France

  • Chart 90: French Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 91: Glance at 2015, 2017 and 2024 French Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 92: French Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 93: Glance at 2015, 2017 and 2024 French Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 94: French Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 95: Glance at 2015, 2017 and 2024 French Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

Italy

  • Chart 96: Italian Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 97: Glance at 2015, 2017 and 2024 Italian Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 98: Italian Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 99: Glance at 2015, 2017 and 2024 Italian Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 100: Italian Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 101: Glance at 2015, 2017 and 2024 Italian Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

Rest of Europe

  • Chart 102: Rest of Europe Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 103: Glance at 2015, 2017 and 2024 Rest of Europe Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 104: Rest of Europe Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 105: Glance at 2015, 2017 and 2024 Rest of Europe Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 106: Rest of Europe Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 107: Glance at 2015, 2017 and 2024 Rest of Europe Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

ASIA-PACIFIC

  • Chart 108: Asia-Pacific Personalized Medicine Market Analysis (2015-2024) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 109: Glance at 2015, 2017 and 2024 Asia-Pacific Personalized Medicine Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 110: Asia-Pacific Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 111: Glance at 2015, 2017 and 2024 Asia-Pacific Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 112: Asia-Pacific Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 113: Glance at 2015, 2017 and 2024 Asia-Pacific Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 114: Asia-Pacific Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 115: Glance at 2015, 2017 and 2024 Asia-Pacific Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

Japan

  • Chart 116: Japanese Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 117: Glance at 2015, 2017 and 2024 Japanese Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 118: Japanese Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 119: Glance at 2015, 2017 and 2024 Japanese Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 120: Japanese Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 121: Glance at 2015, 2017 and 2024 Japanese Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

China

  • Chart 122: Chinese Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 123: Glance at 2015, 2017 and 2024 Chinese Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 124: Chinese Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 125: Glance at 2015, 2017 and 2024 Chinese Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 126: Chinese Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 127: Glance at 2015, 2017 and 2024 Chinese Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

India

  • Chart 128: Indian Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 129: Glance at 2015, 2017 and 2024 Indian Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 130: Indian Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 131: Glance at 2015, 2017 and 2024 Indian Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 132: Indian Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 133: Glance at 2015, 2017 and 2024 Indian Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

Rest of Asia-Pacific

  • Chart 134: Rest of Asia-Pacific Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 135: Glance at 2015, 2017 and 2024 Rest of Asia-Pacific Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 136: Rest of Asia-Pacific Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 137: Glance at 2015, 2017 and 2024 Rest of Asia-Pacific Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 138: Rest of Asia-Pacific Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 139: Glance at 2015, 2017 and 2024 Rest of Asia-Pacific Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

SOUTH AMERICA

  • Chart 140: South America Personalized Medicine Market Analysis (2015-2024) by Geographic Region - Japan, China, India and Rest of South America in USD Million
  • Chart 141: Glance at 2015, 2017 and 2024 South America Personalized Medicine Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 142: South America Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 143: Glance at 2015, 2017 and 2024 South America Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 144: South America Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 145: Glance at 2015, 2017 and 2024 South America Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 146: South America Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 147: Glance at 2015, 2017 and 2024 South America Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

Brazil

  • Chart 148: Brazilian Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 149: Glance at 2015, 2017 and 2024 Brazilian Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 150: Brazilian Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 151: Glance at 2015, 2017 and 2024 Brazilian Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 152: Brazilian Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 153: Glance at 2015, 2017 and 2024 Brazilian Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

Argentina

  • Chart 154: Argentinean Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 155: Glance at 2015, 2017 and 2024 Argentinean Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 156: Argentinean Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 157: Glance at 2015, 2017 and 2024 Argentinean Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 158: Argentinean Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 159: Glance at 2015, 2017 and 2024 Argentinean Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

Rest of South America

  • Chart 160: Rest of South America Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 161: Glance at 2015, 2017 and 2024 Rest of South America Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 162: Rest of South America Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 163: Glance at 2015, 2017 and 2024 Rest of South America Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 164: Rest of South America Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 165: Glance at 2015, 2017 and 2024 Rest of South America Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications

REST OF WORLD

  • Chart 166: Rest of World Personalized Medicine Market Analysis (2015-2024) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness in USD Million
  • Chart 167: Glance at 2015, 2017 and 2024 Rest of World Personalized Medicine Market Share (%) by Product Type - Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics and Personalized Nutrition & Wellness
  • Chart 168: Rest of World Personalized Medicine Market Analysis (2015-2024) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies in USD Million
  • Chart 169: Glance at 2015, 2017 and 2024 Rest of World Personalized Medicine Market Share (%) by Technology - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies
  • Chart 170: Rest of World Personalized Medicine Market Analysis (2015-2024) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications in USD Million
  • Chart 171: Glance at 2015, 2017 and 2024 Rest of World Personalized Medicine Market Share (%) by Application - Oncology, Central Nervous System (CNS), Immunology, Respiratory and Other Applications
Back to Top